MedTech Spectrum

Article Name Europe

Masimo SedLine® Brain Function Monitoring Demonstrates Key Benefits in Pediatric Anesthesia

New study highlights improved brain activity assessment and enhanced anesthesia management in children using SedLine® technology

11th June, 2025

Okomera Opens Pre-Orders for Ocentra

Next-Gen Platform Set to Revolutionize Automated Organoid Screening in Drug Discovery and Precision Medicine

09th June, 2025

Onera Health Unveils Promising Clinical Data for Home-Based Sleep Diagnostics at SLEEP 2025

Patch-based polysomnography solution shows strong potential to revolutionize sleep studies with comfort, accuracy, and remote accessibility.

05th June, 2025

Philips Introduces Intelligent 3D Imaging in Europe to Transform Stroke Care

AI-powered technology accelerates diagnosis and treatment for improved patient outcomes

04th June, 2025

Amber Implants Unveils Positive One-Year Clinical Outcomes for VCFix® Spinal System

First-in-human trial data confirms safety, stability, and promising therapeutic benefits for patients with vertebral compression fractures

03rd June, 2025

RaySearch Unveils Advanced Software Solutions for Particle Therapy at PTCOG 63

Next-Generation Tools Aim to Optimize Proton and Carbon Ion Therapy Planning, Efficiency, and Clinical Outcomes

03rd June, 2025

Terumo Neuro Expands Stroke Care Portfolio with SOFIA™ Flow 88 Launch in EMEA

Next-generation aspiration catheter now commercially available across Europe, Middle East, and Africa

02nd June, 2025

SciBase Surpasses 300,000 Patients Tested with Nevisense Skin Cancer Detection System

Milestone highlights growing clinical adoption of AI-powered, non-invasive technology for early melanoma diagnosis.

28th May, 2025

Implantica Showcases RefluxStop™ Breakthrough at Digestive Disease Week 2025

Groundbreaking non-active implant for acid reflux draws global attention and fuels U.S. clinical engagement at world’s premier GI conference.

27th May, 2025

Sequana Medical Secures €6.3M Convertible Funding to Advance alfapump® Therapy for Liver Disease

SFPIM and Existing Shareholders Back Strategic Funding to Support Liver Disease Therapy Advancements.

27th May, 2025

BrightHeart Secures Third FDA Clearance and PCCP Approval for Integrated Fetal Heart Monitoring Solution

First-of-its-kind platform offers real-time fetal heart documentation and congenital heart disease detection, revolutionizing prenatal care and diagnosis.

15th May, 2025

IBA Unveils CASSY® to Revolutionize Radiopharmaceutical Production

Compact, stackable module designed to boost efficiency and flexibility in radiometal synthesis

13th May, 2025

Lightcast Launches Envisia™ Platform to Revolutionize Antibody Discovery

Limited Release Targets Biotech Innovators with Real-Time Droplet-Based Assays to Accelerate Therapeutic Discovery

12th May, 2025

Osteotec Signs Exclusive Distribution Agreement with icotec ag to Advance Spine Tumour Therapy in Great Britain

The exclusive distribution agreement introduces icotec's innovative BlackArmor® Carbon/PEEK implants, advancing treatment options for spinal tumour patients in Great Britain.

12th May, 2025

Mediso Advances Cryogen-Free MRI with Tech Transfer from SSI

Strategic milestone enables in-house magnet manufacturing for systems up to 9.4T

12th May, 2025

Dawn Health and Merck Launch Advanced Digital Platform for Growth Disorder Management

Next-generation ecosystem enhances treatment adherence, remote monitoring, and personalized support for patients with growth hormone disorders.

07th May, 2025

Implantica Expands RefluxStop™ Access with New Center of Excellence in Spain

Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region.

06th May, 2025

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months.

06th May, 2025